PHARMACYTE BIOTECH INC (PMCB)
US71715X2036 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to PMCB. The Buy consensus is the weighted average rating of the current analysts ratings.
PMCB was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about PMCB.
In the previous month the buy percentage consensus was at a similar level.
PMCB was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-11-08 | HC Wainwright & Co. | Initiate | Neutral |